Antiretroviral Treatment Current Events | Antiretroviral Treatment News
|
| Page
1 of
10 |
194 Results |
|
|
|
Sort By:
Page Views | Date |
ADVERSE EFFECTS OF ANTIRETROVIRAL TREATMENT FOR HIV INFECTION (p1320)
It is well known that treatment of HIV-1 infection (that may lead to AIDS) has side effects, but there are few studies of how many people having treatment are affected by adverse reactions. In a study of 1160 people receiving antiretroviral treatment, published in The Lancet this week, Jacques Fallon and colleagues from the Swiss HIV Cohort Study... view more... (2001-10-17)
Action needed to avoid HIV drug resistance in Africa
We should stop and think about the risks of resistance, and ways of minimising them, before increasing access to antiretroviral therapy in Africa, argue researchers in this week's BMJ. view more (2004-01-29)
EARLY ASSESSMENT PREDICTS LONG-TERM EFFICACY OF HIV-1 ANTIRETROVIRAL THERAPY (p 1760)
A study in this week's issue of THE LANCET highlights how very early (one week) assessment can reliably predict the long-term effectiveness of antiretroviral therapy for HIV-1. Early assessment of antiretroviral drug efficacy is important for the prevention of the emergence of drug-resistant virus and unnecessary exposure to ineffective and toxic... view more... (2001-11-21)
Certain HIV treatment less effective when used with anti-TB therapy
Patients receiving rifampicin-based anti-tuberculosis therapy are more likely to experience virological failure when starting nevirapine-based antiretroviral therapy, an HIV treatment that is widely used in developing countries because of lower cost, than when starting efavirenz-based antiretroviral therapy. view more (2008-08-04)
Gains in access to antiretroviral treatment come with some costs
In this week's PLoS Medicine magazine, Yibeltal Assefa, from the National HIV/AIDS Prevention and Control Office in Addis Ababa, and colleagues describe the successes and challenges of the scale-up of antiretroviral treatment (ART) across Ethiopia. view more (2009-04-28)
Women with AIDS face cervical cancer threat
According to a report issued last week by UNAIDS, access to antiretroviral therapy is beginning to reduce AIDS mortality worldwide. view more (2007-12-03)
Successful Implementation Of Pilot Study For Hiv Antiretroviral Therapy In Uganda (p 34)
Authors of a study in this week's issue of THE LANCET report on the successful implementation of a UNAIDS/Uganda Health Ministry initiative to provide antiretroviral treatment to people with HIV/AIDS in Uganda. Little is known about how to implement complex HIV-1 treatment programmes in resource-limited countries. Paul Weidle from the Centers for... view more... (2002-07-03)
HIV drug resistance is increasing in the UK
The prevalence of transmitted HIV drug resistance in the United Kingdom is increasing, according to a study in this week's BMJ. This finding emphasises the urgent need for new approaches to encourage safer sexual behaviour. A total of 69 patients infected with HIV between June 1994 and August 2000 were evaluated for resistance within 18 months of... view more... (2001-05-02)
When should children infected with HIV start medication
The advent of effective medications for treating HIV dramatically improved the outlook for both adults and children infected with HIV who had access to treatment, but the optimal timing for starting treatment remains controversial, particularly in children. view more (2008-03-25)
Study finds major interruptions in antiretroviral therapy after release from prison
The vast majority of HIV-infected Texas prison inmates who receive antiretroviral therapy while incarcerated experience significant interruptions in HIV treatment after their release into the community. view more (2009-02-25)
Has HIV Become More Virulent?
Damage to patients' immune systems is happening sooner now than it did at the beginning of the HIV epidemic, suggesting the virus has become more virulent. view more (2009-04-08)
LIPODYSTROPHY RISK FROM HIV-1 THERAPY (p 592)
The risk of lipodystrophy (abnormal fat distribution) in HIV-1 individuals undergoing antiretroviral therapy cannot be attributed to one antiretroviral agent, conclude authors of a study in this week's issue of THE LANCET. Lipodystrophy among HIV-1-infected patients receiving antiretroviral therapy was formally described as a clinical entity in... view more... (2001-02-21)
New Study Shows Benefit of Early Therapy in HIV-infected Infants
Antiretroviral therapy (ART) for infants born with HIV infection may be most effective when given in their first five months of life, according to a study published in the April 1 issue of The Journal of Infectious Diseases, now available online. view more (2006-03-09)
Increasing access to antiretroviral drugs would drastically cut AIDS deaths in South Africa
More that 1.2 million deaths could be prevented in South Africa over the next five years by accelerating efforts to provide access to antiretroviral therapy (ART), according to a study released online today by the Journal of Infectious Diseases. view more (2008-03-27)
Markers of inflammation and blood-clotting tied to hazards of intermittent HIV treatment
Episodic treatment of HIV/AIDS with antiretroviral drugs increases the overall risk of death when compared with continuous antiretroviral treatment (ART), but the reasons why have been unknown. view more (2008-10-22)
Study finds limited options for backup HIV treatment in some developing countries
Thai researchers have discovered that patients who fail treatment with a commonly used, inexpensive, first-line antiretroviral therapy (ART) are also usually resistant to other, similar drugs, leaving progressively fewer options for replacement therapies. view more (2007-01-09)
Study finds limited options for backup HIV treatment in some developing countries
Thai researchers have discovered that patients who fail treatment with a commonly used, inexpensive, first-line antiretroviral therapy (ART) are also usually resistant to other, similar drugs, leaving progressively fewer options for replacement therapies. view more (2007-01-09)
Ethnic differences in response to HIV medicines
Researchers from the University of Massachusetts and the University of Pennsylvania have shown that race/ethnicity is a predictor of plasma lipids in patients with HIV-1 on HAART (highly active antiretroviral therapy). view more (2006-01-24)
HIV persists in the gut despite long-term HIV therapy
Even with effective anti-HIV therapies, doctors still have not been able to eradicate the virus from infected individuals who are receiving such treatments, largely because of the persistence of HIV in hideouts known as viral reservoirs. view more (2008-02-14)
New Approaches To HIV Treatment In Less-developed Countries (pp 404, 410)
Two Viewpoint articles in this week's issue of THE LANCET highlight how the use of highly-active antiretroviral therapy (HAART) for HIV-1 treatment - currently only widely available in industrialised countries - could become accessible in less-developed settings. Both articles suggest new strategies for implementing HAART using infrastructure... view more... (2001-08-01)
|
|
| Page
1 of
10 |
194 Results |
|
|
|
Sort By:
Page Views | Date |
|
